Purple Biotech (XTAE:PPBT) Accounts Payable & Accrued Expense : ₪23.52 Mil (As of Mar. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Accounts Payable & Accrued Expense?

Purple Biotech's quarterly accounts payable & accrued expense increased from Sep. 2023 (₪22.64 Mil) to Dec. 2023 (₪26.21 Mil) but then declined from Dec. 2023 (₪26.21 Mil) to Mar. 2024 (₪23.52 Mil).

Purple Biotech's annual accounts payable & accrued expense increased from Dec. 2021 (₪15.18 Mil) to Dec. 2022 (₪25.72 Mil) and increased from Dec. 2022 (₪25.72 Mil) to Dec. 2023 (₪26.21 Mil).

Purple Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Purple Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Accounts Payable & Accrued Expense Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

8.95

10.83

15.18

25.72

26.21

Purple Biotech Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															20.34	17.58	22.64	26.21	23.52

Purple Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.